04/07/2013 The America Invents Act (AIA) has invoked significant changes to the U.S. patent system, a principal one being creation of Inter Partes Review (IPR), and concurrent elimination of the inter partes reexamination. Like the latter, the new Inter Partes Review is an administrative proceeding to invalidate patents, by allowing a party to petition the [...]

Read More

06/17/2013 In April 2012, the Second Circuit in United States v. Aleynikov reversed the defendant’s conviction under the Economic Espionage Act (EEA) holding that the misappropriated trade secrets were not sufficiently related to a product produced for or placed in interstate or foreign commerce, as required under Section 1832(a). The defendant, a former employee at [...]

Read More

07/06/2013 The June 2013 Supreme Court decision in Association for Molecular Pathology v. Myriad Genetics, 569 U.S. 12-398 (2013) which considered whether portions of human genes may be patented, fueled an extraordinary amount of heated discussion for an intellectual property case. The patents at issue in Myriad concern mutated genes associated with increased risk of breast [...]

Read More

03/18/2013   The America Invents Act (AIA) creates new administrative trial procedures to challenge patentability outside litigation before a district court venue. These trial procedures are namely (1) Post Grant Review (PGR), (2) Inter Partes Review (IPR) and (3) a transitional program for covered business method patents. These laws went into effect on September 16, [...]

Read More

03/19/2013 The America Invents Act (AIA) creates new administrative trial procedures to challenge patentability outside litigation before a district court venue. These trial procedures are namely (1) Post Grant Review (PGR), (2) Inter Partes Review (IPR) and (3) a transitional program for covered business method patents. These laws went into effect on September 16, 2012. [...]

Read More

Popular

  • High Technologies

    In today’s rapidly expanding technological world, IPLL is uniquely qualified to represent the high technologies. Our counsel have advanced and industry experience in key...

    Read More
  • Intellectual Property Litigation

    IPLL’s intellectual property (IP) litigation practice covers all aspects of intellectual property disputes. Included categories are complex and Patent Litigation, Abbreviated New Drug Application...

    Read More
  • Banking and Finance

    Corporate finance and banking are central to IPLL clients. Our banking and finance practice area covers venture capital financing of start-up companies and capital...

    Read More
  • Chemical

    IPLL helps clients with developing chemical patent portfolios to build a solid business foundation, ultimately increasing market value. We prepare and prosecute patent applications...

    Read More
  • Claim Construction & Disclaimer –Federal Circuit Sides with the University of Minnesota

    07/01/2013 In Regents of the University of Minnesota v. AGA Medical Corp., No. 12-1167 (Fed. Cir. June 3, 2013), the Federal Circuit affirmed the...

    Read More

News

Top Rated

Latest